The short version
- The most-cited lion's mane trial randomised 30 Japanese adults aged 50 to 80 with mild cognitive impairment to 3g a day or placebo for 16 weeks; scores rose significantly, then decreased significantly within four weeks of stopping.
- A 2019 randomised trial of Hericium erinaceus used three cognitive instruments and only one, the Mini Mental State Examination, improved significantly.
- Pooling the MMSE results from one randomised trial and one pilot trial gave a weighted mean increase of 1.17 points on a 30-point screening instrument.
- A 2025 systematic review found fifteen laboratory studies against five randomised controlled trials, meaning the nerve growth factor mechanism people cite comes overwhelmingly from cells and animals rather than people.
- In a pilot of 41 healthy adults aged 18 to 45, a single 1.8g dose sped up Stroop task performance at 60 minutes, but the authors described their overall results as tentative with null and limited negative findings.
The human evidence for lion's mane and cognition can be counted on two hands. That is not a criticism — it is just the actual size of the dataset, and it is dramatically smaller than the volume of confident content built on top of it. So let us go through it trial by trial, because the details are where the useful information lives.
The 2009 trial everyone is quoting
Mori and colleagues ran a double-blind, parallel-group, placebo-controlled trial in Japanese men and women aged 50 to 80 with diagnosed mild cognitive impairment. After a two-week preliminary period, 30 subjects were randomised into two groups of 15. The lion's mane group took four 250mg tablets, containing 96% Hericium erinaceus dry powder, three times a day — three grams daily — for 16 weeks. Cognition was measured on a scale based on the Revised Hasegawa Dementia Scale.
At weeks 8, 12 and 16, the supplemented group scored significantly higher than placebo, and scores rose with duration of intake. Then the researchers did something most supplement trials don't: they kept watching for four weeks after everyone stopped. The scores decreased significantly. No adverse effects showed up in laboratory testing.
Two things follow. First, this is a genuine, well-designed positive result — in fifteen people per arm, in older adults with existing impairment, on one Japanese dementia-screening scale. Second, whatever it was doing, it stopped doing it within a month of stopping. This is not a change you bank and walk away from.
The 2019 trial that reported all three of its tests
Saitsu and colleagues ran a randomised, double-blind, placebo-controlled parallel-group study of H. erinaceus fruiting body over 12 weeks, using three separate instruments: the Mini Mental State Examination, the Benton visual retention test, and a standard verbal paired-associate learning test.
The MMSE improved significantly. The Benton test and the verbal learning test did not. The authors report this plainly — "MMSE alone showed that oral intake of H. erinaceus significantly improved cognitive functions."
One instrument out of three is a real finding and a modest one, and it is the kind of detail that vanishes when a study becomes a bullet point on a product page.
The healthy-adult data is where it gets mixed
Almost all of the older work is in cognitively compromised populations. Docherty and colleagues went the other way, testing 41 healthy adults aged 18–45 on 1.8g of H. erinaceus in a double-blind, placebo-controlled, parallel-groups pilot, measuring both an acute effect at 60 minutes and a chronic effect over 28 days.
What they found: participants performed the Stroop task faster 60 minutes after a single dose (p = 0.005), and there was a trend toward reduced subjective stress after 28 days that did not reach significance (p = 0.051). What they also found, in their own words, were "null and limited negative findings." They describe the results as tentative and explicitly warn that the sample is small.
So: one speed measure moved acutely in a pilot of 41 people. That is interesting. It is not the same claim as "improves cognition," and the authors are careful not to make it.
What the systematic review adds — and subtracts
A 2025 systematic review in Frontiers in Nutrition pulled together the clinical literature on Hericium erinaceus: five randomised controlled trials, three pilot clinical trials, one cohort study, one case report — and fifteen laboratory studies. That ratio is the single most useful thing in the paper. The mechanistic story you have read about nerve growth factor, BDNF and hippocampal neurogenesis comes overwhelmingly from cells and animals, not from people.
On the human side, the reviewers report that MMSE scores from one RCT and one pilot trial gave a combined weighted mean increase of 1.17 points in the intervention group. On a 30-point screening instrument, that is a small change. The review also notes side effects that are commonly unreported: stomach discomfort, headache and allergic reactions.
The honest summary
Lion's mane has a small human evidence base, concentrated in older adults with existing cognitive impairment, with effects that are statistically real, clinically modest, measured mostly on screening scales, and dependent on continued use. In healthy adults the picture is thinner and less consistent. The exciting mechanism is largely preclinical.
That is a more interesting position than either the hype or the flat dismissal. It is an ingredient with a signal worth taking seriously and an evidence base too small to make promises with.
Rule these out first — we mean it
Before you attribute foggy thinking to a mushroom deficiency: sleep, thyroid function, iron status, B12, alcohol, and the side-effect profile of anything you are already prescribed. Every one of those produces exactly the cognitive picture people buy lion's mane for, and every one of them is more fixable. We would genuinely rather you found a treatable cause than took our capsules for a year.
What we'd actually tell you
If the boring causes are ruled out and you want to try it: give it 8 to 12 weeks, which is the window the trials used, and judge it against something specific you could notice — how often you lose a word, how long you can hold a task — rather than a general feeling. Take it consistently, because Mori's four-week follow-up says the effect goes when the intake goes.
And set the expectation at the size of the evidence. A point on a screening scale is not a personality upgrade. If nothing has changed by week 12, stop; that is information, and it saves you money.
Good questions
How long does lion's mane take to work?
Eight to twelve weeks is the window the human trials used. The 2009 trial in 30 adults with mild cognitive impairment measured significant differences at weeks 8, 12 and 16, with scores rising as intake continued. A pilot in healthy adults found one speed measure improved 60 minutes after a single dose, but that is a single task, not general cognition.
Do the effects last after you stop taking lion's mane?
No. The 2009 trial kept measuring for four weeks after supplementation ended, and scores decreased significantly. Whatever it was doing, it stopped doing it within a month. That matters for how you budget: this is an ongoing cost rather than a change you make once and keep, and it is worth deciding upfront whether you want to repeat that purchase indefinitely.
Does lion's mane do anything if my memory is already fine?
The evidence is much thinner for healthy adults. Most of the trials recruited older people with existing cognitive impairment. The one pilot in 41 healthy adults aged 18 to 45 found faster Stroop performance an hour after a single dose and a non-significant trend on stress at 28 days, and its authors called the results tentative alongside null and limited negative findings.
Does lion's mane have side effects?
Stomach discomfort, headache and allergic reactions are the ones a 2025 systematic review flagged as commonly unreported in the primary studies. The 2009 trial found no adverse effects on laboratory testing in its 30 participants. The honest position is that the safety dataset is small, which is the same limitation that applies to the efficacy dataset.
How big is the benefit people actually saw in the studies?
Small. Pooling MMSE results from one randomised trial and one pilot gave a weighted mean increase of 1.17 points on a 30-point screening instrument. That is a real, measurable difference and it is not a personality upgrade. Set the expectation at the size of the evidence, and if nothing has shifted by week 12, stop taking it.
Sources
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res, 2009. View study
- Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res, 2019. View study
- Docherty S, et al. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients, 2023. View study
- Menon A, et al. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr, 2025. View study
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
